Streetbeat News

Regulatory

MBOT

Microbot Medical Inc. (NASDAQ:MBOT) has successfully completed an extended pre-clinical study of its LIBERTY® Robotic Surgical System in the U.S. The study, conducted by leading interventional radiologists, achieved a 100% success rate with no observable complications. The company received positive feedback regarding the system's intuitiveness, ease of use, and remote operation capabilities. This study is expected to assist in the future adoption of LIBERTY when commercialized.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 12:37 pm

NBSE

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) has presented preclinical data showing that its Stealth Editors are non-immunogenic, which allows for successful redosing in non-human primates without triggering an immune response. The company expects to present additional data on the gene editing capabilities of Stealth Editors throughout the remainder of 2023.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 12:35 pm

IPW

iPower has met the Nasdaq bid price compliance, which means it has maintained a minimum bid price of $1.00 per share for at least 10 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 12:32 pm

JWEL

Jowell Global Ltd. (NASDAQ:JWEL) has been granted an additional 180 days by NASDAQ to meet the minimum closing bid price requirement of $1.00 for continued listing. The company may resort to a reverse stock split to regain compliance. If the company fails to demonstrate compliance by December 26, 2023, its securities may be delisted.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 12:20 pm

XELB

Xcel Brands has regained compliance with NASDAQ's minimum bid price requirement, which may have positive implications for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 12:19 pm

CING

Cingulate Inc. (NASDAQ:CING) has successfully manufactured the clinical supply for upcoming pivotal Phase 3 trials of its lead candidate, CTx-1301 (dexmethylphenidate), for the treatment of attention deficit/hyperactivity disorder (ADHD). The trials are set to begin in July and August. The company recently completed a Phase 3 adult onset and duration study of CTx-1301 with results expected in 3Q 2023. If the trials are successful, Cingulate plans to submit a New Drug Application (NDA) for CTx-1301 in mid-2024.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 12:17 pm

LUMN

CenturyLink Intellectual Property LLC has filed a patent application #20230208891 for an in-line, in-call AI virtual assistant for teleconferencing. The patent application is publicly available for review.

Portfolio Pulse from Charles Gross

June 29, 2023 | 12:12 pm

AKBA

Akebia Therapeutics, Inc. (NASDAQ:AKBA) has announced the top-line results from its Phase 4 IMPACT study of Auryxia, a primary phosphate-lowering therapy for adult patients with chronic kidney disease (CKD) on dialysis. The study, sponsored by U.S. Renal Care Kidney Research in collaboration with Akebia, showed a statistically significant difference in mean monthly erythropoiesis-stimulating agent (ESA) use and a non-significant difference in mean monthly intravenous (IV) iron use. Serious adverse events occurred in 39% of patients receiving Auryxia and 59% in those receiving standard of care (SOC).

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 12:12 pm

LGST

Shares of Semper Paratus Acquisition Corp have been halted due to pending news. The nature of the news is not yet disclosed.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 12:08 pm

AAPL

AMZN

GOOG

META

The U.S. Federal Trade Commission (FTC) plans to prosecute Amazon.com Inc's core online marketplace, alleging that Amazon rewards online merchants using its logistics services and penalizes those who do not. FTC investigators have been preparing the complaint for several months. The FTC has already filed three cases against Amazon, including one last week for allegedly duping Prime customers. The U.S. government's crackdown on Big Tech also includes complaints against Alphabet Inc's Google and Meta Platforms Inc, along with an investigation into Apple Inc.

Portfolio Pulse from Anusuya Lahiri

June 29, 2023 | 12:08 pm